Casgevy

For Taina Maitre, sickle cell disease has meant frequent pain and missed opportunities. Last winter, she was in the hospital for Thanksgiving. And for Christmas. And again, for New Years.

The treatments, both produced by Boston-area companies, join 32 other approved gene therapies and are approved to treat the disease in the United States.